Hikal Q4 Results

  • BSE: 524735
  • NSE: HIKAL
  • ISIN: INE475B01022
  • Sector: Biotechnology & Drugs
BSE
394.13.35 (0.86%)
Volume14.72 K
Updated: Mon 25 Nov, 2024 | 15:29:28
NSE
395.754.70 (1.20%)
Volume2.94 L
Updated: Mon 25 Nov, 2024 | 15:40:09
Today: 389.25
400.40
52-Wk: 260.65
416.15

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Hikal Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 514.10540.20-%545.29-%
    Selling/ General/ Admin Expenses Total 63.7863.28-%57.84-%
    Depreciation/ Amortization 32.3428.27-%26.83-%
    Other Operating Expenses Total 121.61119.09-%117.70-%
    Total Operating Expense 451.98493.89-%482.11-%
    Operating Income 62.1246.31-%63.18-%
    Net Income Before Taxes 47.3235.79-%48.58-%
    Net Income 33.9726.41-%35.99-%
    Diluted Normalized EPS 2.762.14-%2.91-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts